HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.

Abstract
Pathological cardiac hypertrophy is regarded as a critical intermediate step toward the development of heart failure. Many signal transduction cascades are demonstrated to dictate the induction and progression of pathological hypertrophy; however, our understanding in regulatory mechanisms responsible for the suppression of hypertrophy remains limited. In this study, we showed that exacerbated hypertrophy induced by pressure overload in cardiac-deleted Pak1 mice was attributable to a failure to upregulate the antihypertrophic E3 ligase, Fbxo32, responsible for targeting proteins for the ubiquitin-degradation pathway. Under pressure overload, cardiac overexpression of constitutively active Pak1 mice manifested strong resilience against pathological hypertrophic remodeling. Mechanistic studies demonstrated that subsequent to Pak1 activation, the binding of Smad3 on a critical singular AGAC(-286)-binding site on the FBXO32 promoter was crucial for its transcriptional regulation. Pharmacological upregulation of Fbxo32 by Berberine ameliorated hypertrophic remodeling and improved cardiac performance in cardiac-deficient Pak1 mice under pressure overload. Our findings discover Smad3 and Fbxo32 as novel downstream components of the Pak1-dependent signaling pathway for the suppression of hypertrophy. This discovery opens a new venue for opportunities to identify novel targets for the management of cardiac hypertrophy.
AuthorsHoyee Tsui, Min Zi, Shunyao Wang, Sanjoy K Chowdhury, Sukhpal Prehar, Qiangrong Liang, Elizabeth J Cartwright, Ming Lei, Wei Liu, Xin Wang
JournalHypertension (Dallas, Tex. : 1979) (Hypertension) Vol. 66 Issue 6 Pg. 1176-83 (Dec 2015) ISSN: 1524-4563 [Electronic] United States
PMID26483344 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 American Heart Association, Inc.
Chemical References
  • Muscle Proteins
  • Smad3 Protein
  • Berberine
  • Fbxo32 protein, rat
  • SKP Cullin F-Box Protein Ligases
  • p21-Activated Kinases
Topics
  • Animals
  • Animals, Newborn
  • Aorta (pathology)
  • Berberine (pharmacology)
  • Cardiomegaly (genetics, prevention & control)
  • Cells, Cultured
  • Constriction, Pathologic
  • Immunoblotting
  • Male
  • Mice, Knockout
  • Mice, Transgenic
  • Muscle Proteins (genetics, metabolism)
  • Myocytes, Cardiac (cytology, drug effects, metabolism)
  • Phosphorylation
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • SKP Cullin F-Box Protein Ligases (genetics, metabolism)
  • Signal Transduction (drug effects, genetics)
  • Smad3 Protein (genetics, metabolism)
  • Transcriptional Activation
  • p21-Activated Kinases (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: